Antigen Presenting Cell Extracellular Vesicle Instruction Architecture for Adaptive Immune Activation, Memory Programming, and Therapeutic Engineering
Program Code: HEMOREGEN-IMM-001
Division: HEMOREGEN-IMMUNO
Parent Program: HEMOREGEN-721
Classification: Adaptive Immune Communication Platform
Status: Master Foundational Atlas v1.0
EXECUTIVE SUMMARY
The APC-to-T Cell EV Priming Atlas establishes the foundational communication architecture through which Antigen Presenting Cells (APCs) instruct naïve T cells using extracellular vesicles (EVs).
Within PROJECT HEMOREGEN-721, APC-derived EVs are viewed as biological instruction packets that transfer:
- Antigenic information
- Costimulatory signals
- Metabolic programming
- Differentiation instructions
- Immune memory templates
to initiate and regulate adaptive immunity.
This atlas serves as the foundational framework for:
- Cancer EV vaccines
- Personalized neoantigen vaccines
- Infectious disease vaccines
- T-cell engineering
- Immune memory enhancement
- Precision immunotherapy
SECTION I — APC COMMUNICATION HIERARCHY
Tier 1 — Antigen Acquisition Layer
Primary APC Classes
APC Type | Primary Function |
Dendritic Cells | Professional T-cell priming |
Macrophages | Antigen processing and inflammatory instruction |
B Cells | Antigen-specific humoral coordination |
Monocyte-Derived APCs | Emergency inflammatory priming |
Tissue Resident APCs | Local immune surveillance |
Tier 2 — Antigen Processing Layer
Sources
Source | Example |
Viral antigens | Influenza, HIV, SARS-CoV-2 |
Bacterial antigens | Intracellular and extracellular pathogens |
Tumor neoantigens | Mutation-derived peptides |
Vaccine antigens | Recombinant proteins |
Self-antigens | Tolerance-associated peptides |
Processing Compartments
Compartment | Function |
Endosome | Antigen degradation |
Lysosome | Peptide generation |
Endoplasmic Reticulum | MHC loading |
Multivesicular Body | EV cargo packaging |
SECTION II — APC EV BIOGENESIS ARCHITECTURE
Stage 1
Threat Recognition
Pattern Recognition Systems
Receptor | Target |
TLR3 | Viral dsRNA |
TLR4 | Bacterial endotoxin |
TLR7/8 | Viral ssRNA |
TLR9 | CpG DNA |
cGAS-STING | Cytosolic DNA |
Outcome:
APC activation.
Stage 2
Signal Integration
Activated Pathways:
- NF-κB
- STAT1
- STAT3
- IRF3
- IRF7
Outcome:
EV biogenesis induction.
Stage 3
Polarized EV Production
EV Classes:
EV Type | Function |
Exosomes | Instruction delivery |
Microvesicles | Rapid communication |
Apoptotic vesicles | Tolerance and cleanup signaling |
SECTION III — APC EV CARGO ATLAS
Cargo Class A
Antigenic Instruction Layer
Cargo | Function |
MHC-I peptide complexes | CD8 priming |
MHC-II peptide complexes | CD4 priming |
Tumor neoantigens | Anti-cancer immunity |
Viral peptides | Antiviral immunity |
Pathogen-associated motifs | Innate-adaptive bridge |
Cargo Class B
Costimulatory Layer
Molecule | Function |
CD80 | Activation signal |
CD86 | Activation signal |
CD40 | Amplification |
ICAM-1 | Synapse stabilization |
OX40L | Expansion support |
Cargo Class C
Cytokine Programming Layer
Cytokine | Outcome |
IL-12 | TH1 differentiation |
IL-4 | TH2 differentiation |
IL-6 + TGFβ | TH17 differentiation |
IL-21 | TFH differentiation |
IL-10 | Regulatory programming |
Cargo Class D
Regulatory RNA Layer
RNA | Function |
miR-155 | Activation amplification |
miR-146a | Feedback control |
miR-21 | Expansion support |
miR-181a | TCR sensitivity enhancement |
lncRNA modules | Long-term programming |
Cargo Class E
Metabolic Programming Layer
Cargo | Function |
ATP-associated signals | Activation support |
NAD+ regulators | Metabolic adaptation |
Glycolytic enzymes | Effector programming |
Mitochondrial RNAs | Bioenergetic reprogramming |
SECTION IV — EV ADDRESSING AND TARGETING SYSTEM
Address Layer A
Synapse Docking Architecture
APC Marker | T Cell Partner |
ICAM-1 | LFA-1 |
CD58 | CD2 |
MHC-I | TCR-CD8 |
MHC-II | TCR-CD4 |
Purpose:
Physical stabilization.
Address Layer B
Antigen Recognition Code
Determines:
- Specificity
- Clonal selection
- Immune memory potential
Address Layer C
Costimulation Authorization Code
APC EV Cargo | T Cell Receptor |
CD80/CD86 | CD28 |
CD40 | CD40L |
OX40L | OX40 |
Purpose:
Prevent anergy.
SECTION V — T CELL DIFFERENTIATION ATLAS
TH1 Program
APC EV Signature
- IL-12
- IFN-associated signals
- miR-155
Outcome:
Cell-mediated immunity.
Applications:
- Viral infection
- Cancer immunity
TH2 Program
APC EV Signature
- IL-4
- IL-13-supportive cargo
Outcome:
Humoral immunity.
TH17 Program
APC EV Signature
- IL-6
- TGFβ
Outcome:
Barrier defense.
TFH Program
APC EV Signature
- IL-21
- CXCR5-associated programming
Outcome:
Germinal center development.
TREG Program
APC EV Signature
- IL-10
- TGFβ
- miR-146a
Outcome:
Tolerance induction.
SECTION VI — APC → CD8 CROSS-PRIMING NETWORK
Phase 1
Antigen Transfer
Cargo:
- MHC-I peptide complexes
Phase 2
Activation
Cargo:
- CD80
- CD86
- IL-12
Phase 3
Expansion
Cargo:
- IL-2-associated signals
- miR-21
Phase 4
Effector Programming
Cargo:
- Cytotoxic differentiation modules
Phase 5
Memory Formation
Cargo:
- BCL6-associated regulators
- Epigenetic programming factors
SECTION VII — IMMUNE MEMORY PROGRAMMING ARCHITECTURE
Short-Term Memory
Characteristics:
- Rapid recall
- Effector dominance
Central Memory
Characteristics:
- Long persistence
- Secondary expansion potential
Tissue Resident Memory
Characteristics:
- Local protection
- Barrier immunity
EV Memory Cargo
Cargo | Function |
BCL6 regulators | Memory stability |
TCF1 regulators | Stem-like persistence |
Epigenetic modulators | Long-term programming |
Survival factors | Memory maintenance |
SECTION VIII — APC EV FAILURE ATLAS
Failure Type 1
Antigen Loading Defect
Outcome:
Poor immunity.
Failure Type 2
Costimulation Defect
Outcome:
Anergy.
Failure Type 3
Checkpoint Dominance
Outcome:
T-cell exhaustion.
Failure Type 4
Tolerance Leakage
Outcome:
Autoimmunity.
Failure Type 5
EV Cargo Degradation
Outcome:
Reduced signaling fidelity.
SECTION IX — HEMOREGEN BIOMARKER PANEL
APC Identity Markers
- CD11c
- HLA-DR
- CD80
- CD86
EV Identity Markers
- CD9
- CD63
- CD81
Activation Markers
- IL-12
- IFN-related proteins
- CD40
RNA Biomarkers
- miR-155
- miR-146a
- miR-21
- miR-181a
Memory Biomarkers
- TCF1-associated cargo
- BCL6-associated cargo
SECTION X — HEMOREGEN THERAPEUTIC ENGINEERING BLUEPRINT
HEM-RX-001A
Cancer Neoantigen APC-EV Vaccine Platform
Purpose:
Patient-specific oncology vaccines.
HEM-RX-001B
Universal Viral APC-EV Vaccine Platform
Purpose:
Rapid outbreak response.
HEM-RX-001C
Memory-Amplifying APC-EV Platform
Purpose:
Long-duration immunity.
HEM-RX-001D
Tolerance-Inducing APC-EV Platform
Purpose:
Autoimmune disease modulation.
HEM-RX-001E
Synthetic Programmable APC-EV Platform
Purpose:
Precision immune programming.
SECTION XI — SCF FIVE PRINCIPLE ALIGNMENT
SCF Principle | APC EV Application |
Targeted Drug Action | Antigen-specific T-cell programming |
Pharmacokinetic Optimization | Localized immune synapse delivery |
Metabolic Efficiency | Coordinated metabolic activation |
Resistance Prevention | Multi-signal activation architecture |
Safety Profile | Controlled differentiation and tolerance balancing |
TRANSLATIONAL DEVELOPMENT ROADMAP
H1 — Mapping
- APC cargo atlas
- EV address atlas
- T-cell response atlas
H2 — Validation
- Human PBMC systems
- Organoid models
- Antigen-specific assays
H3 — Engineering
- Vaccine EV platforms
- Memory EV platforms
- Personalized oncology EVs
H4 — Biomarker Development
- Companion diagnostics
- Vaccine response monitoring
H5 — Clinical Translation
- IND-enabling studies
- First-in-human APC-EV vaccines
- Precision immunotherapy programs
MASTER REGISTRY INDEX
HEMOREGEN-IMM-001 — APC-to-T Cell EV Priming Atlas
HEM-RX-001 — Engineered APC-EV Vaccine Platform
HEM-RX-001A — Cancer Neoantigen APC-EV Vaccine Platform
HEM-RX-001B — Universal Viral APC-EV Vaccine Platform
HEM-RX-001C — Memory-Amplifying APC-EV Platform
HEM-RX-001D — Tolerance-Inducing APC-EV Platform
HEM-RX-001E — Synthetic Programmable APC-EV Platform
HEMOREGEN-721-PROG-0001 — Project HEMOREGEN-721 Master Program
SCF-IMM-PRIME-0001 — APC Immune Priming Systems Atlas
SCF-IMM-MEMORY-0001 — EV-Mediated Adaptive Immune Memory Architecture